For Jake Becraft, Ph.D., the future of America’s biomedical innovation isn’t just playing out in the lab—it's being shaped by ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund ...

Grogan served as assistant to President Trump and director of the Domestic Policy Council 2019-2020. On April 15, President Trump issued an awaited executive order on drug pricing, kicking off a new ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Maher Masoud, CEO of MaxCyte, explains how the current environment is impacting the entrepreneurial spirit in the ...

Central Ohio is a growing U.S. biotech hub because of decades of efforts, the head of a national trade group says.

If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are up about 235%. That is the pitch for ...

Frankie Zhao came to the United States from Harbin, China in 2014 to pursue a degree in chemical engineering at Rice University in Houston, Texas. During their junior year, they worked in a molecular ...